Drug
K201 compound clinical trials
Also written K201.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Other names
- K201
- 2
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses K201 compound is read from its arms, and is right about nine times in ten.
Testing it · 4
- Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial FibrillationTerminatedPhase 2Sequel Pharmaceuticals, IncNCT01259622Written as K201
- Phase 2 Study of Oral K201 for Prevention of AF RecurrenceTerminatedPhase 2Sequel Pharmaceuticals, IncNCT01067833Written as K201 Tablet
- Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial FibrillationCompletedPhase 2Sequel Pharmaceuticals, IncNCT00626652Written as K201 Injection
- Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind StudyCompletedPhase 1/2Moberg Pharma ABNCT00863005Written as K201
Codes
What other systems call K201 compound · ClinicalTrials.gg INT004030
- MeSH (NLM) C109183K201 compoundOne source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C109183 | K201 compound | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.